Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
about
Serum amyloid A: an acute-phase protein involved in tumour pathogenesisA cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex.Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a feasibility study.Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3
P2860
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
@ast
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
@en
type
label
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
@ast
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
@en
prefLabel
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
@ast
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.
@en
P2093
P1433
P1476
Effects of interleukin-3 after chemotherapy for advanced ovarian cancer
@en
P2093
Limburg PC
Sleijfer DT
Vellenga E
Willemse PH
P304
P407
P577
1992-09-01T00:00:00Z